At present, the treatment of lymphoma mostly adopts comprehensive treatment, i.e., according to different tumors, different pathological types and subtypes, different biological behaviors, different stages of disease and development tendency, different behavioral states of the organism and important organ functions, the existing various treatments are planned and rationally applied with a view to maximizing the protection of the organism, maximizing the killing of the tumor cells, and to achieve the purpose of increasing the cure rate and improving the quality of life. The The treatment of non-Hodgkin’s b-cell lymphoma is mainly based on chemotherapy. For lymphoplasmacytic lymphoma, follicular lymphoma and other inert lymphomas, the disease develops slowly, and chemoradiotherapy is effective, but not suitable for remission. Surgery combined with radiotherapy also has a high cure rate or remission rate for malignant lymphoma, and the targeted therapy and stem cell transplantation in recent years have greatly improved the prognosis of lymphoma. For primitive immune cell lymphoma, diffuse large b-cell lymphoma and other aggressive lymphomas, regardless of the stage, cyclophosphamide, adriamycin, vincristine, prednisone regimen chemotherapy is used.